SCHEMBL30406206

SCHEMBL30406206

CC1CCN(C(=O)c2ccc(-c3nc4ccc(O)cc4s3)cc2)CC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SULT1A1 P50225 4/20 0.53
▸ APP P05067 8/20 0.51
▸ SMN1; SMN2 Q16637 3/20 0.51
▸ MAPT P10636 3/20 0.51
▸ NPC1 O15118 1/20 0.51
▸ MITF O75030 1/20 0.51
▸ TP53 P04637 1/20 0.51
▸ NFKB1 P19838 1/20 0.51
▸ RAB9A P51151 1/20 0.51
▸ NFKB2 Q00653 1/20 0.51
▸ RELA Q04206 1/20 0.51
▸ HPGD P15428 3/20 0.50
▸ CLK1 P49759 1/20 0.50
▸ DYRK1A Q13627 1/20 0.50
▸ DYRK1B Q9Y463 1/20 0.50
▸ ALDH1A1 P00352 2/20 0.49
▸ MGLL Q99685 2/20 0.49
▸ LMNA P02545 1/20 0.49
▸ KDM4E B2RXH2 1/20 0.49
▸ CYP2D6 P10635 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2549277 1.00 SULT1A1 (0.53) SULT1A1APPSMN1; SMN2MAPTNPC1
SCHEMBL19072456 0.82 SULT1A1 (0.44) SULT1A1APPMAPTCLK1DYRK1A
SCHEMBL14916518 0.77 CA12 (0.46) SMN1; SMN2MAPTNPC1TP53RAB9A
SCHEMBL14157073 0.77 APP (0.68) SULT1A1APPSMN1; SMN2MAPTNPC1
SCHEMBL14925266 0.75 CLK1 (0.56) SULT1A1APPSMN1; SMN2MAPTTP53
SCHEMBL18475959 0.75 ACHE (0.72) SMN1; SMN2MAPTNPC1TP53RAB9A
SCHEMBL5423269 0.74 APP (0.81) SULT1A1APPSMN1; SMN2MAPTNPC1
SCHEMBL4512023 0.73 NPC1 (0.76) SMN1; SMN2MAPTNPC1TP53RAB9A
SCHEMBL10722678 0.72 ACHE (0.82) SMN1; SMN2MAPTNPC1TP53RAB9A
SCHEMBL11887840 0.72 KDM4E (0.78) SULT1A1APPSMN1; SMN2MAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110172051-B IRE-1 alpha inhibitors 复星弘创(苏州)医药科技有限公司 2023-03-07 — — CN disclosed
Send feedback